Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV002512018 | SCV002822787 | uncertain significance | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | FASTKD2: PM2, BP4 |
Labcorp Genetics |
RCV002512018 | SCV004669530 | likely benign | not provided | 2024-03-09 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005025844 | SCV005647680 | uncertain significance | Combined oxidative phosphorylation deficiency 44 | 2024-02-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003943417 | SCV004757426 | likely benign | FASTKD2-related disorder | 2020-03-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |